The landscape of clinical research has expanded significantly beyond the controlled environment of randomised clinical trials. As the industry seeks to understand how treatments perform in broader patient populations, the reliance on observational data has grown.
However, the transition from raw data to actionable insight is fraught with challenges. A significant number of projects do not achieve their objectives, not due to a lack of data, but due to a lack of structure. This is why robust data governance, specifically led by Clinical Research Organisations (CROs), has become a critical success factor for Real World Evidence Studies.